Allan Prochazka
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 11 | 2023 | 440 | 1.860 |
Why?
| | Informed Consent | 6 | 2022 | 189 | 0.930 |
Why?
| | Internal Medicine | 7 | 2016 | 273 | 0.920 |
Why?
| | Preventive Health Services | 5 | 2020 | 154 | 0.920 |
Why?
| | Diagnostic Tests, Routine | 3 | 2014 | 110 | 0.820 |
Why?
| | Disease | 2 | 2013 | 102 | 0.760 |
Why?
| | Health Status Indicators | 2 | 2013 | 163 | 0.750 |
Why?
| | Early Diagnosis | 2 | 2013 | 244 | 0.740 |
Why?
| | Hospitalists | 3 | 2013 | 251 | 0.710 |
Why?
| | Cancer Survivors | 5 | 2025 | 302 | 0.690 |
Why?
| | Physical Examination | 3 | 2015 | 242 | 0.670 |
Why?
| | Down Syndrome | 3 | 2021 | 506 | 0.630 |
Why?
| | Stress Disorders, Post-Traumatic | 3 | 2016 | 861 | 0.550 |
Why?
| | Motivational Interviewing | 3 | 2016 | 118 | 0.530 |
Why?
| | Weight Reduction Programs | 2 | 2016 | 117 | 0.530 |
Why?
| | Anticoagulants | 3 | 2007 | 675 | 0.500 |
Why?
| | Varenicline | 1 | 2016 | 29 | 0.480 |
Why?
| | Quality of Health Care | 4 | 2018 | 658 | 0.470 |
Why?
| | Internship and Residency | 5 | 2016 | 1240 | 0.470 |
Why?
| | Comprehension | 3 | 2014 | 183 | 0.470 |
Why?
| | Veterans | 8 | 2023 | 1525 | 0.450 |
Why?
| | Patient Readmission | 4 | 2015 | 708 | 0.450 |
Why?
| | Nicotinic Agonists | 1 | 2016 | 136 | 0.440 |
Why?
| | Telemedicine | 3 | 2023 | 894 | 0.420 |
Why?
| | Patient Satisfaction | 3 | 2015 | 697 | 0.410 |
Why?
| | Educational Measurement | 1 | 2016 | 319 | 0.410 |
Why?
| | Warfarin | 2 | 2005 | 153 | 0.400 |
Why?
| | Telenursing | 1 | 2013 | 10 | 0.400 |
Why?
| | Combat Disorders | 1 | 2013 | 41 | 0.390 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 179 | 0.380 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 283 | 0.380 |
Why?
| | Iraq War, 2003-2011 | 1 | 2013 | 140 | 0.380 |
Why?
| | Students, Medical | 2 | 2016 | 369 | 0.370 |
Why?
| | Afghan Campaign 2001- | 1 | 2013 | 153 | 0.370 |
Why?
| | Hospitalization | 4 | 2016 | 2264 | 0.370 |
Why?
| | Gastric Bypass | 1 | 2013 | 119 | 0.360 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 248 | 0.350 |
Why?
| | Bibliometrics | 1 | 2012 | 65 | 0.350 |
Why?
| | Patient Discharge | 3 | 2015 | 933 | 0.350 |
Why?
| | Preoperative Care | 1 | 2014 | 372 | 0.350 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1057 | 0.340 |
Why?
| | Humans | 65 | 2025 | 141754 | 0.330 |
Why?
| | Overweight | 1 | 2015 | 588 | 0.330 |
Why?
| | Publishing | 1 | 2012 | 145 | 0.320 |
Why?
| | Depression | 3 | 2016 | 1508 | 0.310 |
Why?
| | Weight Loss | 1 | 2015 | 791 | 0.310 |
Why?
| | Tobacco Use Disorder | 3 | 2023 | 245 | 0.310 |
Why?
| | Obesity, Morbid | 1 | 2013 | 273 | 0.310 |
Why?
| | Adult | 27 | 2021 | 39391 | 0.310 |
Why?
| | Primary Health Care | 3 | 2015 | 1809 | 0.300 |
Why?
| | Lung Neoplasms | 4 | 2023 | 2567 | 0.300 |
Why?
| | Ethics, Medical | 2 | 2012 | 85 | 0.290 |
Why?
| | United States | 18 | 2021 | 15310 | 0.290 |
Why?
| | Smoking | 4 | 2017 | 1603 | 0.280 |
Why?
| | Aged | 20 | 2023 | 24746 | 0.280 |
Why?
| | Publications | 1 | 2008 | 51 | 0.270 |
Why?
| | Attitude of Health Personnel | 4 | 2016 | 1183 | 0.270 |
Why?
| | Ofloxacin | 2 | 2005 | 17 | 0.260 |
Why?
| | Levofloxacin | 2 | 2005 | 20 | 0.260 |
Why?
| | International Normalized Ratio | 2 | 2005 | 48 | 0.260 |
Why?
| | Vena Cava Filters | 1 | 2007 | 64 | 0.260 |
Why?
| | Rheumatology | 1 | 2008 | 115 | 0.260 |
Why?
| | Physicians | 5 | 2016 | 942 | 0.260 |
Why?
| | Physician-Patient Relations | 5 | 2015 | 585 | 0.260 |
Why?
| | Research Design | 2 | 2020 | 1146 | 0.250 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2010 | 96 | 0.250 |
Why?
| | Middle Aged | 22 | 2021 | 34647 | 0.240 |
Why?
| | Rehabilitation Centers | 2 | 2015 | 38 | 0.230 |
Why?
| | Obesity | 2 | 2016 | 3008 | 0.230 |
Why?
| | Pulmonary Embolism | 1 | 2007 | 239 | 0.230 |
Why?
| | Nortriptyline | 1 | 2004 | 9 | 0.230 |
Why?
| | Male | 29 | 2021 | 70179 | 0.220 |
Why?
| | Physicians, Family | 2 | 2009 | 195 | 0.220 |
Why?
| | Medical Staff, Hospital | 2 | 2016 | 82 | 0.220 |
Why?
| | Female | 30 | 2021 | 75943 | 0.220 |
Why?
| | Communication | 5 | 2014 | 951 | 0.210 |
Why?
| | Teaching Rounds | 2 | 2016 | 73 | 0.210 |
Why?
| | Biomarkers | 2 | 2022 | 4190 | 0.210 |
Why?
| | Burnout, Professional | 2 | 2010 | 459 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2015 | 97 | 0.200 |
Why?
| | Telerehabilitation | 1 | 2023 | 40 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 239 | 0.190 |
Why?
| | Confidence Intervals | 3 | 2021 | 329 | 0.190 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2004 | 185 | 0.190 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2025 | 192 | 0.190 |
Why?
| | Surveys and Questionnaires | 12 | 2021 | 5974 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Follow-Up Studies | 6 | 2018 | 5212 | 0.180 |
Why?
| | Hearing Aids | 1 | 2023 | 85 | 0.180 |
Why?
| | Nicotine | 1 | 2004 | 350 | 0.180 |
Why?
| | Leisure Activities | 1 | 2021 | 30 | 0.170 |
Why?
| | Time Factors | 9 | 2021 | 6966 | 0.170 |
Why?
| | Neoplasms | 3 | 2025 | 2747 | 0.170 |
Why?
| | Cohort Studies | 5 | 2018 | 5815 | 0.160 |
Why?
| | Smoking Prevention | 2 | 2017 | 184 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2008 | 1406 | 0.160 |
Why?
| | Hearing Loss | 1 | 2023 | 235 | 0.160 |
Why?
| | Retrospective Studies | 7 | 2020 | 16374 | 0.150 |
Why?
| | Quality of Life | 5 | 2025 | 3014 | 0.150 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 434 | 0.140 |
Why?
| | Odds Ratio | 2 | 2012 | 1057 | 0.130 |
Why?
| | Logistic Models | 4 | 2021 | 2092 | 0.130 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 29 | 0.130 |
Why?
| | Financing, Organized | 1 | 2016 | 39 | 0.130 |
Why?
| | Medicaid | 1 | 2020 | 451 | 0.120 |
Why?
| | Cross-Sectional Studies | 7 | 2023 | 5697 | 0.120 |
Why?
| | Prenatal Care | 1 | 2018 | 303 | 0.120 |
Why?
| | Evidence-Based Medicine | 3 | 2016 | 750 | 0.120 |
Why?
| | Contraindications | 1 | 2015 | 85 | 0.120 |
Why?
| | Clinical Competence | 2 | 2014 | 1205 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 962 | 0.120 |
Why?
| | Learning | 2 | 2016 | 439 | 0.120 |
Why?
| | Preventive Medicine | 1 | 2015 | 40 | 0.120 |
Why?
| | Decision Support Systems, Management | 1 | 2015 | 6 | 0.120 |
Why?
| | Surgeons | 1 | 2020 | 336 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2018 | 240 | 0.110 |
Why?
| | Risk Assessment | 4 | 2015 | 3508 | 0.110 |
Why?
| | Patient Care | 1 | 2016 | 120 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2025 | 1634 | 0.110 |
Why?
| | Disclosure | 2 | 2012 | 112 | 0.110 |
Why?
| | Pilot Projects | 3 | 2023 | 1826 | 0.110 |
Why?
| | Teaching | 1 | 2016 | 237 | 0.110 |
Why?
| | Treatment Outcome | 7 | 2025 | 11181 | 0.110 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 711 | 0.110 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2014 | 47 | 0.100 |
Why?
| | Costs and Cost Analysis | 2 | 2013 | 222 | 0.100 |
Why?
| | Curriculum | 2 | 2013 | 1039 | 0.100 |
Why?
| | Data Interpretation, Statistical | 2 | 2014 | 377 | 0.100 |
Why?
| | Medication Adherence | 1 | 2018 | 513 | 0.100 |
Why?
| | Faculty, Medical | 1 | 2016 | 296 | 0.100 |
Why?
| | Incidental Findings | 1 | 2014 | 80 | 0.100 |
Why?
| | Patient Transfer | 1 | 2015 | 181 | 0.100 |
Why?
| | Guidelines as Topic | 2 | 2013 | 275 | 0.100 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 35 | 0.100 |
Why?
| | Drug Interactions | 2 | 2005 | 406 | 0.100 |
Why?
| | Inpatients | 2 | 2017 | 512 | 0.100 |
Why?
| | Nursing Homes | 1 | 2015 | 172 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2013 | 2765 | 0.100 |
Why?
| | Patient Care Management | 1 | 2013 | 56 | 0.100 |
Why?
| | Mental Recall | 1 | 2014 | 210 | 0.100 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 258 | 0.100 |
Why?
| | Early Medical Intervention | 1 | 2013 | 60 | 0.090 |
Why?
| | Research | 1 | 2016 | 455 | 0.090 |
Why?
| | Administration, Oral | 2 | 2005 | 803 | 0.090 |
Why?
| | Pharmacists | 1 | 2015 | 263 | 0.090 |
Why?
| | Health Literacy | 1 | 2014 | 176 | 0.090 |
Why?
| | Morbidity | 1 | 2013 | 322 | 0.090 |
Why?
| | Government Regulation | 1 | 2012 | 51 | 0.090 |
Why?
| | Self Care | 1 | 2015 | 395 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1344 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2015 | 7923 | 0.090 |
Why?
| | Methotrexate | 1 | 2013 | 255 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 175 | 0.090 |
Why?
| | Perception | 1 | 2014 | 378 | 0.090 |
Why?
| | Risk | 1 | 2014 | 907 | 0.090 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2012 | 134 | 0.090 |
Why?
| | Primary Prevention | 1 | 2013 | 202 | 0.090 |
Why?
| | Adolescent | 5 | 2021 | 22130 | 0.090 |
Why?
| | Nurse's Role | 1 | 2013 | 167 | 0.090 |
Why?
| | Drug Therapy, Combination | 2 | 2004 | 1041 | 0.090 |
Why?
| | Hospital Costs | 1 | 2012 | 122 | 0.090 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 88 | 0.080 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 212 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 122 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2015 | 534 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2018 | 860 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1027 | 0.080 |
Why?
| | Mortality | 1 | 2013 | 359 | 0.080 |
Why?
| | Antirheumatic Agents | 1 | 2013 | 298 | 0.080 |
Why?
| | Hospitals | 1 | 2015 | 696 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1570 | 0.080 |
Why?
| | Work Schedule Tolerance | 2 | 2010 | 52 | 0.080 |
Why?
| | Decision Making | 2 | 2014 | 961 | 0.080 |
Why?
| | Information Dissemination | 1 | 2012 | 224 | 0.080 |
Why?
| | Colorado | 5 | 2020 | 4629 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2013 | 854 | 0.080 |
Why?
| | Health Care Surveys | 2 | 2015 | 566 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 444 | 0.070 |
Why?
| | Exercise | 1 | 2021 | 2112 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2014 | 3356 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 681 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2013 | 1027 | 0.070 |
Why?
| | Databases, Bibliographic | 1 | 2008 | 32 | 0.070 |
Why?
| | Age Factors | 4 | 2015 | 3294 | 0.070 |
Why?
| | Counseling | 3 | 2023 | 398 | 0.070 |
Why?
| | Beneficence | 1 | 2008 | 20 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 313 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1317 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 353 | 0.070 |
Why?
| | Patient Care Team | 1 | 2013 | 673 | 0.070 |
Why?
| | Job Satisfaction | 2 | 2010 | 224 | 0.070 |
Why?
| | Social Justice | 1 | 2008 | 84 | 0.070 |
Why?
| | Surgical Procedures, Operative | 1 | 2010 | 270 | 0.070 |
Why?
| | Alcoholism | 1 | 2014 | 823 | 0.070 |
Why?
| | Patient Education as Topic | 2 | 2012 | 779 | 0.070 |
Why?
| | Gastroenterology | 1 | 2009 | 185 | 0.060 |
Why?
| | Thromboembolism | 1 | 2007 | 118 | 0.060 |
Why?
| | Linear Models | 3 | 2014 | 858 | 0.060 |
Why?
| | Age Distribution | 1 | 2007 | 397 | 0.060 |
Why?
| | Child | 3 | 2020 | 22414 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1077 | 0.060 |
Why?
| | Colonoscopy | 1 | 2008 | 251 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 25 | 0.060 |
Why?
| | Quality Improvement | 1 | 2014 | 1254 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 741 | 0.060 |
Why?
| | Lung | 3 | 2023 | 4137 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 42 | 0.060 |
Why?
| | Biomedical Research | 1 | 2012 | 708 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2938 | 0.060 |
Why?
| | Azithromycin | 1 | 2005 | 98 | 0.050 |
Why?
| | Administration, Cutaneous | 1 | 2004 | 129 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2006 | 280 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1178 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1268 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 361 | 0.050 |
Why?
| | Probability | 1 | 2004 | 309 | 0.050 |
Why?
| | Reference Values | 1 | 2004 | 807 | 0.050 |
Why?
| | Immunologic Tests | 1 | 2022 | 16 | 0.050 |
Why?
| | Hospitals, Veterans | 2 | 2017 | 255 | 0.050 |
Why?
| | HIV Infections | 1 | 2018 | 3022 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2004 | 771 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2004 | 1989 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 333 | 0.050 |
Why?
| | Tobacco Products | 1 | 2023 | 98 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2022 | 168 | 0.050 |
Why?
| | Fluoxetine | 1 | 2002 | 57 | 0.050 |
Why?
| | Public Opinion | 1 | 2002 | 68 | 0.050 |
Why?
| | Health Maintenance Organizations | 1 | 2002 | 107 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 257 | 0.040 |
Why?
| | Health Behavior | 1 | 2007 | 792 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 475 | 0.040 |
Why?
| | Risk Factors | 4 | 2021 | 10482 | 0.040 |
Why?
| | Medicare | 2 | 2020 | 808 | 0.040 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 54 | 0.040 |
Why?
| | Young Adult | 2 | 2015 | 13749 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2013 | 2096 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2022 | 353 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 134 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 132 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 216 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2008 | 805 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2064 | 0.040 |
Why?
| | Data Collection | 2 | 2013 | 662 | 0.040 |
Why?
| | Prospective Studies | 2 | 2018 | 7777 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 138 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 504 | 0.040 |
Why?
| | Continuity of Patient Care | 2 | 2014 | 287 | 0.040 |
Why?
| | Behavior Therapy | 1 | 2002 | 282 | 0.040 |
Why?
| | Length of Stay | 2 | 2015 | 1263 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1748 | 0.040 |
Why?
| | Walking | 1 | 2023 | 548 | 0.040 |
Why?
| | Attitude to Health | 1 | 2002 | 458 | 0.040 |
Why?
| | Electronic Health Records | 2 | 2017 | 1132 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2010 | 1321 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2002 | 566 | 0.030 |
Why?
| | Community Health Services | 1 | 2018 | 233 | 0.030 |
Why?
| | Formative Feedback | 1 | 2016 | 29 | 0.030 |
Why?
| | Behavior | 1 | 2016 | 93 | 0.030 |
Why?
| | Self Report | 1 | 2021 | 861 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2002 | 587 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2799 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 824 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2016 | 170 | 0.030 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 2014 | 9 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 759 | 0.030 |
Why?
| | Alaska | 1 | 2014 | 86 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2014 | 296 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 881 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2016 | 531 | 0.030 |
Why?
| | Physician-Nurse Relations | 1 | 2013 | 18 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 115 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2016 | 368 | 0.020 |
Why?
| | Health Services Research | 1 | 2015 | 406 | 0.020 |
Why?
| | Models, Psychological | 1 | 2014 | 313 | 0.020 |
Why?
| | Patient Rights | 1 | 2012 | 11 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 82 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2012 | 54 | 0.020 |
Why?
| | Focus Groups | 1 | 2014 | 572 | 0.020 |
Why?
| | Computer-Assisted Instruction | 1 | 2012 | 68 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 997 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 150 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 930 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 60 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2016 | 550 | 0.020 |
Why?
| | Patient Care Planning | 1 | 2012 | 155 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 208 | 0.020 |
Why?
| | Seizures | 1 | 2014 | 442 | 0.020 |
Why?
| | Physician's Role | 1 | 2012 | 219 | 0.020 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2010 | 52 | 0.020 |
Why?
| | Documentation | 1 | 2012 | 199 | 0.020 |
Why?
| | Endarterectomy, Carotid | 1 | 2010 | 55 | 0.020 |
Why?
| | Motivation | 1 | 2015 | 603 | 0.020 |
Why?
| | Prostatectomy | 1 | 2010 | 102 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2012 | 333 | 0.020 |
Why?
| | Pregnancy | 2 | 2018 | 7092 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 521 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2063 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 619 | 0.020 |
Why?
| | Observation | 1 | 2008 | 56 | 0.020 |
Why?
| | Patient Participation | 1 | 2012 | 432 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 464 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1866 | 0.020 |
Why?
| | Health Personnel | 1 | 2014 | 738 | 0.020 |
Why?
| | Medicine | 1 | 2009 | 125 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 431 | 0.020 |
Why?
| | Postoperative Care | 1 | 2009 | 280 | 0.020 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2010 | 187 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1015 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2135 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 579 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2903 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2075 | 0.010 |
Why?
| | Registries | 1 | 2013 | 2144 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2009 | 768 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1498 | 0.010 |
Why?
| | Reimbursement Mechanisms | 1 | 2002 | 83 | 0.010 |
Why?
| | Medical Records | 1 | 2002 | 182 | 0.010 |
Why?
| | Telephone | 1 | 2002 | 182 | 0.010 |
Why?
| | Anxiety | 1 | 2008 | 1090 | 0.010 |
Why?
| | Mass Screening | 1 | 2008 | 1313 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 177 | 0.010 |
Why?
| | Regression Analysis | 1 | 2002 | 1023 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2002 | 1249 | 0.010 |
Why?
| | Health Promotion | 1 | 2002 | 759 | 0.010 |
Why?
|
|
Prochazka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|